These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 11453920

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
    Cieza-Díaz DE, Prieto-Torres L, Rodríguez-Pinilla SM, Córdoba Mascuñano R, Manso Alonso R, Machan S, Piris Pinilla MÁ, Requena Caballero L.
    Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.
    Kamstrup MR, Ralfkiaer E, Skovgaard GL, Gniadecki R.
    Br J Dermatol; 2008 Apr; 158(4):747-53. PubMed ID: 18241263
    [Abstract] [Full Text] [Related]

  • 26. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M, Tomita A, Takata K, Shimoyama Y, Yoshino T, Tomita Y, Nakamura S.
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM.
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [Abstract] [Full Text] [Related]

  • 31. Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant.
    Miquel J, Vourc'h-Jourdain M, Thomas C, Cassagnau E, Stalder JF, Barbarot S.
    Clin Exp Dermatol; 2013 Oct; 38(7):741-4. PubMed ID: 24073656
    [Abstract] [Full Text] [Related]

  • 32. CD30+ Lymphoproliferative Disorders of the Skin.
    Sauder MB, O'Malley JT, LeBoeuf NR.
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
    [Abstract] [Full Text] [Related]

  • 33. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W.
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
    Su LD, Schnitzer B, Ross CW, Vasef M, Mori S, Shiota M, Mason DY, Pulford K, Headington JT, Singleton TP.
    J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA.
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.